newsfilter
← Latest News
Business Wire·

Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference

  • Niagen Bioscience (NASDAQ: NAGE) senior management will present at the East Coast IDEAS Investor Conference on Thursday, June 11, 2026, at The Westin Times Square in New York, NY.
  • CEO Rob Fried will deliver a presentation from 2:40 - 3:15 PM ET in the Presenting Room, with the session livestreamed at www.threepartadvisors.com/east-coast.
  • CFO Ozan Pamir will attend the conference to host one-on-one meetings with institutional investors.
  • Investors can schedule meetings by contacting their conference representative or emailing Niagen@KCSA.com.
  • Niagen Bioscience is the global authority on NAD+ science & healthy aging research, focusing on advancing healthspan through precision science.
  • The company's portfolio includes Niagen® (patented nicotinamide riboside), which powers Tru Niagen® (the top U.S. NAD+ boosting oral supplement based on 2025 e-commerce revenue) & Niagen™ Plus (pharmaceutical-grade IV & injectable products available via prescription at clinics).
  • Niagen Bioscience collaborates with independent investigators at esteemed universities & maintains state-of-the-art laboratories with rigorous quality protocols.
  • The company holds a robust patent portfolio protecting NR & other NAD+ precursors, with financial information published at www.niagenbioscience.com.